Using artificial intelligence to give pharma and biotech a leg up
Unique AI method developed at Chalmers for generating proteins could speed up drug development
Preclinical Research
New study maps wildlife microbiota for human benefit
Wild Biotech says it is discovering millions of previously unknown potential human therapeutics
Deep brain stimulation for Parkinson's disease
New discoveries suggest it is on par with therapeutics and speeds the process of recovery and adoption of personalized treatment
Connecting biology with machine learning
Broad Institute launches the Eric and Wendy Schmidt Center for better understanding programs of life
Bringing siRNA across the barrier
Bioasis announces publication evaluating CNS delivery of siRNA via the company’s xB³ platform
Focus Feature on Neuroscience: Preclinical progress on neurodegeneration
Making the rounds of brain-related therapeutic and diagnostic R&D, with a focus on neurodegenerative disease and dementia
Real world evidence market is growing fast
Applications of RWE-based insights range from drug discovery to supporting regulatory decision-making
Teaming science while spreading risk—It’s a lottery that works
It takes real strength of character to accept the high risk in pharma and biotech and not be psychologically crippled by it
Synthetic lethal drugs vs. cancer
Company obtains funding to advance precision oncology
Advances in Fabry disease
Amicus’ engineered hGLA showed greater substrate reduction than wildtype hGLA
